Skip to main content
SpringerLink
Log in

Colorectal Cancer: Metastatic (Palliation)

  • Reference work entry
The ASCRS Textbook of Colon and Rectal Surgery

Abstract

Approximately 20% of patients with colorectal cancer present with established distant metastases. In most cases, the metastases are detectable with noninvasive imaging, and patients can be assigned to AJCC (American Joint Committee on Cancer) Stage IV before any surgical intervention. Among these patients there is enormous heterogeneity with respect to sites of disease, extent of disease, symptoms, performance status, and comorbidities. The clinical spectrum at the time of diagnosis ranges from the asymptomatic patient with a single metastatic lesion to the rapidly deteriorating patient with colon obstruction and advanced, multiorgan metastases. It is therefore difficult to define rigid treatment algorithms that can be widely applied to all clinical settings.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Jemal A, Murray T, WardE, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55(1):10–30.

    PubMed  Google Scholar 

  2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96(19):1420–1425.

    PubMed  Google Scholar 

  3. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J Clin Oncol 1992;10(6):904–911.

    Google Scholar 

  4. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993;306(6880):752–755.

    CAS  PubMed  Google Scholar 

  5. Tournigand C, Andre T, AchilleE, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22(2): 229–237.

    CAS  PubMed  Google Scholar 

  6. Hurwitz H, Fehrenbacher L, NovotnyW, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350(23):2335–2342.

    CAS  PubMed  Google Scholar 

  7. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100(1):57–70.

    CAS  PubMed  Google Scholar 

  8. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002;12(2):89–96.

    PubMed  Google Scholar 

  9. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997;80(8 suppl):1529–1537.

    CAS  PubMed  Google Scholar 

  10. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty‐eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50(19):6130–6138.

    CAS  PubMed  Google Scholar 

  11. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial award lecture. Cancer Res 1986;46(2):467–473.

    CAS  PubMed  Google Scholar 

  12. Hynes RO. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants—or both? Cell 2003;113(7):821–823.

    CAS  PubMed  Google Scholar 

  13. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003;22(42):6524–6536.

    CAS  PubMed  Google Scholar 

  14. Chambers AF, Groom AC, Mac Donald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2(8):563–572.

    CAS  PubMed  Google Scholar 

  15. Al‐Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium‐attached tumor cells: a new model for metastasis. Nat Med 2000;6(1):100–102.

    PubMed  Google Scholar 

  16. Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, Mac Donald IC, Groom AC. Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin North Am 2001; 10(2):243–255, vii.

    CAS  Google Scholar 

  17. Shevde LA, Welch DR. Metastasis suppressor pathways: an evolving paradigm. Cancer Lett 2003;198(1):1–20.

    CAS  PubMed  Google Scholar 

  18. Chin BB, Wahl RL. 18F‐Fluoro‐2‐deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Gut 2003;52(suppl 4):iv23–29.

    PubMed  Google Scholar 

  19. Deans GT, Krukowski ZH, Irwin ST. Malignant obstruction of the left colon. Br J Surg 1994;81(9):1270–1276.

    CAS  PubMed  Google Scholar 

  20. Phillips RK, Hittinger R, Fry JS, Fielding LP. Malignant large bowel obstruction. Br J Surg 1985;72(4):296–302.

    CAS  PubMed  Google Scholar 

  21. Gandrup P, Lund L, Balslev I. Surgical treatment of acute malignant large bowel obstruction. Eur J Surg 1992;158(8):427–430.

    CAS  PubMed  Google Scholar 

  22. Loizou LA, Grigg D, Boulos PB, Bown SG. Endoscopic Nd:YAG laser treatment of rectosigmoid cancer. Gut 1990;31(7):812–816.

    CAS  PubMed  Google Scholar 

  23. Daneker GW Jr, Carlson GW, Hohn DC, Lynch P, Roubein L, Levin B. Endoscopic laser recanalization is effective for prevention and treatment of obstruction in sigmoid and rectal cancer. Arch Surg 1991;126(11):1348–1352.

    PubMed  Google Scholar 

  24. Mandava N, Petrelli N, Herrera L, Nava H. Laser palliation for colorectal carcinoma. Am J Surg 1991;162(3):212–214; discussion 215.

    CAS  PubMed  Google Scholar 

  25. Brunetaud JM, Maunoury V, Cochelard D. Lasers in rectosigmoid tumors. Semin Surg Oncol 1995;11(4):319–327.

    CAS  PubMed  Google Scholar 

  26. Gevers AM, Macken E, Hiele M, Rutgeerts P. Endoscopic laser therapy for palliation of patients with distal colorectal carcinoma: analysis of factors influencing long‐term outcome. Gastrointest Endosc 2000;51(5):580–585.

    CAS  PubMed  Google Scholar 

  27. Salvati EP, Rubin RJ, Eisenstat TE, Siemons GO, Mangione JS. Electrocoagulation of selected carcinoma of the rectum. Surg Gynecol Obstet 1988;166(5):393–396.

    CAS  PubMed  Google Scholar 

  28. Eisenstat TE, Oliver GC. Electrocoagulation for adenocarcinoma of the low rectum. World J Surg 1992;16(3):458–462.

    CAS  PubMed  Google Scholar 

  29. Camunez F, Echenagusia A, Simo G, Turegano F, Vazquez J, Barreiro‐Meiro I. Malignant colorectal obstruction treated by means of self‐expanding metallic stents: effectiveness before surgery and in palliation. Radiology 2000;216(2):492–497.

    CAS  PubMed  Google Scholar 

  30. Law WL, Choi HK, Lee YM, Chu KW. Palliation for advanced malignant colorectal obstruction by self‐expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum 2004;47(1):39–43.

    PubMed  Google Scholar 

  31. Rosen SA, Buell JF, YoshidaA, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we b? Arch Surg 2000;135(5):530–534; discussion 534–535.

    CAS  PubMed  Google Scholar 

  32. Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005;12(8): 637–645.

    PubMed  Google Scholar 

  33. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196(5):722–728.

    PubMed  Google Scholar 

  34. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6(7):651–657.

    CAS  PubMed  Google Scholar 

  35. Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 2004;22(17):3475–3484.

    PubMed  Google Scholar 

  36. Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ, O'Riordain DS. Non‐operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001;88(10):1352–1356.

    CAS  PubMed  Google Scholar 

  37. Moran MR, Rothenberger DA, Lahr CJ, Buls JG, Goldberg SM. Palliation for rectal cancer. Resection? Anastomosis? Arch Surg 1987;122(6):640–643.

    CAS  PubMed  Google Scholar 

  38. Longo WE, Ballantyne GH, Bilchik AJ, Modlin IM. Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 1988;31(11):842–847.

    CAS  PubMed  Google Scholar 

  39. Chu QD, Davidson RS, Rodriguez‐Bigas MA, Wirtzfeld DA, Petrelli NJ. Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectu? J Surg Oncol 2002;81(1):3–7.

    PubMed  Google Scholar 

  40. Nash GM, Saltz LB, KemenyNE, et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002;9(10): 954–960.

    PubMed  Google Scholar 

  41. Crane CH, Janjan NA, AbbruzzeseJL, et al. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys 2001;49(1):107–116.

    CAS  PubMed  Google Scholar 

  42. McCarter MD, Fong Y. Metastatic liver tumors. Semin Surg Oncol 2000;19(2):177–188.

    CAS  PubMed  Google Scholar 

  43. Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin 1999;49(4):231–255.

    CAS  PubMed  Google Scholar 

  44. Adam R, Avisar E, AricheA, et al. Five‐year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8(4):347–353.

    CAS  PubMed  Google Scholar 

  45. Clavien PA, Selzner N, Morse M, Selzner M, Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra‐arterial chemotherapy. Surgery 2002;131(4):433–442.

    PubMed  Google Scholar 

  46. Blumgart LH, Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 1995;32(5):333–421.

    CAS  PubMed  Google Scholar 

  47. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984;199(5):502–508.

    CAS  PubMed  Google Scholar 

  48. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2(3):285–288.

    CAS  PubMed  Google Scholar 

  49. Kronawitter U, Kemeny NE, Heelan R, Fata F, Fong Y. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999;86(2):229–235.

    CAS  PubMed  Google Scholar 

  50. Kim HC, Kim TK, SungKB, et al. CT during hepatic arteriography and portography: an illustrative review. Radiographics 2002;22(5):1041–1051.

    PubMed  Google Scholar 

  51. Poyanli A, Sencer S. Computed tomography scan of the liver. Eur J Radiol 1999;32(1):15–20.

    CAS  PubMed  Google Scholar 

  52. Hann LE, Winston CB, Brown KT, Akhurst T. Diagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy. Semin Surg Oncol 2000;19(2): 94–115.

    CAS  PubMed  Google Scholar 

  53. Fong Y, Blumgart LH, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 1995;222(4):426–434; discussion 434–437.

    CAS  PubMed  Google Scholar 

  54. D'Angelica MI, Shoup MC, Nissan A. Randomized clinical trials in advanced and metastatic colorectal carcinoma. Surg Oncol Clin North Am 2002;11(1):173–191.

    Google Scholar 

  55. Rougier P, Van Cutsem E, BajettaE, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998;352(9138):1407–1412.

    CAS  PubMed  Google Scholar 

  56. Cunningham D, Pyrhonen S, JamesRD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352(9138):1413–1418.

    CAS  PubMed  Google Scholar 

  57. Saltz LB, Cox JV, BlankeC, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343(13):905–914.

    CAS  PubMed  Google Scholar 

  58. Douillard JY, Cunningham D, RothAD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first‐line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355(9209):1041–1047.

    CAS  PubMed  Google Scholar 

  59. Kuebler JP, de Gramont A. Recent experience with oxaliplatin or irinotecan combined with 5‐fluorouracil and leucovorin in the treatment of colorectal cancer. Semin Oncol 2003;30(4 suppl 15):40–46.

    CAS  PubMed  Google Scholar 

  60. de Gramont A, Figer A, SeymourM, et al. Leucovorin and fluorouracil with or without oxaliplatin as first‐line treatment in advanced colorectal cancer. J Clin Oncol 2000;18(16): 2938–2947.

    CAS  PubMed  Google Scholar 

  61. Goldberg RM, Morton RF, Sargent DJ, et al. N9741: oxaliplatin (oxal) or CPT‐11 + 5‐fluorouracil (5FU)/leucovorin (LV) or oxal + CPT‐11 in advanced colorectal cancer (CRC). Initial toxicity and response data from a GI Intergroup study. Proc Am Soc Clin Oncol 2002;21(128a):abstract 511.

    Google Scholar 

  62. O'Neil BH. Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents. Semin Radiat Oncol 2003;13(4):441–453.

    PubMed  Google Scholar 

  63. Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to “small” and “large” tumors. Surgery 1969;66(6):1067–1072.

    CAS  PubMed  Google Scholar 

  64. Oberfield RA, McCaffrey JA, Polio J, Clouse ME, Hamilton T. Prolonged and continuous percutaneous intra‐arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979;44(2):414–423.

    CAS  PubMed  Google Scholar 

  65. Weiss GR, Garnick MB, OsteenRT, et al. Long‐term hepatic arterial infusion of 5‐fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol 1983;1(5):337–344.

    CAS  PubMed  Google Scholar 

  66. Balch CM, Urist MM, Soong SJ, McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983;198(5): 567–573.

    CAS  PubMed  Google Scholar 

  67. Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984;53(6):1336–1343.

    CAS  PubMed  Google Scholar 

  68. Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta‐analysis of the published literature. Cancer 1996;78(8):1639–1645.

    CAS  PubMed  Google Scholar 

  69. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta‐Analysis Group in Cancer. J Natl Cancer Inst 1996;88(5):252–258.

    Google Scholar 

  70. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000;18(2):243–254.

    CAS  PubMed  Google Scholar 

  71. Kerr DJ, McArdle CS, LedermannJ, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 2003;361(9355):368–373.

    CAS  PubMed  Google Scholar 

  72. Kemeny N, Niedzwiecki D, Hollis DR. Hepatic arterial infusion (HAI) versus systemic therapy for hepatic metastases from colorectal cancer: a CALGB randomized trial of efficacy, quality of life (QOL), cost effectiveness, and molecular markers. Proc Am Soc Clin Oncol 2003;22(abstr 1010):252.

    Google Scholar 

  73. Leonard GD, Fong Y, Jarnagin W. Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases. 2004 ASCO Annual Meeting Proceedings (Post‐Meeting Edition). J Clin Oncol 2004; 22(14S):3542.

    Google Scholar 

  74. Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989;124(9): 1021–1022.

    CAS  PubMed  Google Scholar 

  75. Foster JH, Berman MM. Solid Liver Tumors. Philadelphia: Elsevier‐Health Sciences Division; 1997.

    Google Scholar 

  76. Jarnagin WR, Gonen M, FongY, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236(4): 397–406; discussion 406–407.

    PubMed  Google Scholar 

  77. Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978;135(3):389–394.

    CAS  PubMed  Google Scholar 

  78. D'Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y. Ninety‐six five‐year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 1997;185(6): 554–559.

    PubMed  Google Scholar 

  79. Scheele J, Stangl R, Altendorf‐Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991;110(1):13–29.

    CAS  PubMed  Google Scholar 

  80. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991;78(7):797–801.

    CAS  PubMed  Google Scholar 

  81. Rosen CB, Nagorney DM, TaswellHF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216(4):493–504; discussion 504–505.

    CAS  PubMed  Google Scholar 

  82. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990;16(4):360–365.

    CAS  PubMed  Google Scholar 

  83. Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984;199(3): 306–316.

    CAS  PubMed  Google Scholar 

  84. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230(3):309–318; discussion 318–321.

    CAS  PubMed  Google Scholar 

  85. Fong Y, Cohen AM, FortnerJG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15(3):938–946.

    CAS  PubMed  Google Scholar 

  86. Petrowsky H, Gonen M, JarnaginW, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi‐institutional analysis. Ann Surg 2002;235(6):863–871.

    PubMed  Google Scholar 

  87. Lorenz M, Muller HH, SchrammH, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5‐fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998;228(6):756–762.

    CAS  PubMed  Google Scholar 

  88. Kemeny MM, Adak S, GrayB, et al. Combined‐modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy—an intergroup study. J Clin Oncol 2002;20(6):1499–1505.

    PubMed  Google Scholar 

  89. Kemeny N, Huang Y, CohenAM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341(27):2039–2048.

    CAS  PubMed  Google Scholar 

  90. Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 2003;10(4):338–347.

    PubMed  Google Scholar 

  91. Nordlinger B, Rougier P. Nonsurgical methods for liver metastases including cryotherapy, radiofrequency ablation, and infusional treatment: what's new in 200? Curr Opin Oncol 2002;14(4):420–423.

    PubMed  Google Scholar 

  92. McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum 1979;22(8): 553–556.

    CAS  PubMed  Google Scholar 

  93. McAfee MK, Allen MS, Trastek VF, Ilstrup DM, Deschamps C, Pairolero PC. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 1992;53(5):780–785; discussion 785–786.

    CAS  PubMed  Google Scholar 

  94. Nagakura S, Shirai Y, Yamato Y, Yokoyama N, Suda T, Hatakeyama K. Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection. J Am Coll Surg 2001;193(2):153–160.

    CAS  PubMed  Google Scholar 

  95. Dematteo R, Minnard EA, Kemeny N. Outcome after resection of both liver and lung metastases in patients with colorectal cancer. Proc Am Soc Clin Oncol 1999. Abstr 958.

    Google Scholar 

  96. Rizk NP, Downey RJ. Resection of pulmonary metastases from colorectal cancer. Semin Thorac Cardiovasc Surg 2002;14(1): 29–34.

    PubMed  Google Scholar 

  97. Roth JA, Pass HI, Wesley MN, White D, Putnam JB, Seipp C. Comparison of median sternotomy and thoracotomy for resection of pulmonary metastases in patients with adult soft‐tissue sarcomas. Ann Thorac Surg 1986;42(2):134–138.

    CAS  PubMed  Google Scholar 

  98. McCormack PM, Bains MS, BeggCB, et al. Role of video‐assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 1996;62(1):213–216; discussion 216–217.

    CAS  PubMed  Google Scholar 

  99. Sugarbaker PH, Cunliffe WJ, BelliveauJ, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16(4 suppl 6):83–97.

    CAS  PubMed  Google Scholar 

  100. Dawson LE, Russell AH, Tong D, Wisbeck WM. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 1983;22(2):95–99.

    CAS  PubMed  Google Scholar 

  101. Russell AH, Tong D, DawsonLE, et al. Adenocarcinoma of the retroperitoneal ascending and descending colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. Int J Radiat Oncol Biol Phys 1983; 9(3):361–365.

    CAS  PubMed  Google Scholar 

  102. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989;63(2): 364–367.

    CAS  PubMed  Google Scholar 

  103. Willett CG, Tepper JE, Cohen AM, Orlow E, Welch CE. Failure patterns following curative resection of colonic carcinoma. Ann Surg 1984;200(6):685–690.

    CAS  PubMed  Google Scholar 

  104. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130(4):387–393.

    CAS  PubMed  Google Scholar 

  105. Sadeghi B, Arvieux C, GlehenO, et al. Peritoneal carcinomatosis from non‐gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88(2):358–363.

    CAS  PubMed  Google Scholar 

  106. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993;72(5):1631–1636.

    CAS  PubMed  Google Scholar 

  107. Gilly FN, Beaujard A, GlehenO, et al. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I–II study. Anticancer Res 1999;19(3B):2317–2321.

    CAS  PubMed  Google Scholar 

  108. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82:359–374.

    CAS  PubMed  Google Scholar 

  109. Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum 2000;43(10): 1341–1346; discussion 1347–1348.

    CAS  PubMed  Google Scholar 

  110. Jayne DG, Fook S, Loi C, Seow‐Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002;89(12): 1545–1550.

    CAS  PubMed  Google Scholar 

  111. Midgley R, Kerr D. Colorectal cancer. Lancet 1999;353(9150): 391–399.

    CAS  PubMed  Google Scholar 

  112. Machover D. A comprehensive review of 5‐fluorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer 1997;80(7):1179–1187.

    CAS  PubMed  Google Scholar 

  113. Sugarbaker PH. Colorectal carcinomatosis: a new oncologic frontier. Curr Opin Oncol 2005;17(4):397–399.

    PubMed  Google Scholar 

  114. Speyer JL. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Semin Oncol 1985; 12(3 suppl 4):23.–28.

    CAS  PubMed  Google Scholar 

  115. Sugarbaker PH, Graves T, De BruijnEA, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990;50(18): 5790–5794.

    CAS  PubMed  Google Scholar 

  116. Sugarbaker PH, Schellinx ME, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20(5):585–591; discussion 592.

    CAS  PubMed  Google Scholar 

  117. Culliford ATT, Brooks AD, SharmaS, et al. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 2001;8(10):787–795.

    PubMed  Google Scholar 

  118. Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA. Long‐term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2005;12(1):65–71.

    PubMed  Google Scholar 

  119. Elias D, Blot F, El OtmanyA, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92(1):71–76.

    CAS  PubMed  Google Scholar 

  120. Verwaal VJ, van Ruth S, de BreeE, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21(20):3737–3743.

    PubMed  Google Scholar 

  121. Ulbright TM, Roth LM, Stehman FB. Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 1984; 53(5):1164–1174.

    CAS  PubMed  Google Scholar 

  122. Webb MJ, Decker DG, Mussey E. Cancer metastatic to the ovary: factors influencing survival. Obstet Gynecol 1975; 45(4):391–396.

    CAS  PubMed  Google Scholar 

  123. Israel SL, Helsel EV Jr, Hausman DH. The challenge of metastatic ovarian carcinoma. Am J Obstet Gynecol 1965; 93(8):1094–1101.

    CAS  PubMed  Google Scholar 

  124. Demopoulos RI, Touger L, Dubin N. Secondary ovarian carcinoma: a clinical and pathological evaluation. Int J Gynecol Pathol 1987;6(2):166–175.

    CAS  PubMed  Google Scholar 

  125. Barr SS, Valiente MA, Bacon HE. Rationale of bilateral oophorectomy concomitant with resection for carcinoma of the rectum and colon. Dis Colon Rectum 1962;5:450–452.

    CAS  PubMed  Google Scholar 

  126. Blamey S, McDermott F, Pihl E, Price AB, Milne BJ, Hughes E. Ovarian involvement in adenocarcinoma of the colon and rectum. Surg Gynecol Obstet 1981;153(1):42–44.

    CAS  PubMed  Google Scholar 

  127. Morrow M, Enker WE. Late ovarian metastases in carcinoma of the colon and rectum. Arch Surg 1984;119(12):1385–1388.

    CAS  PubMed  Google Scholar 

  128. Cutait R, Lesser ML, Enker WE. Prophylactic oophorectomy in surgery for large‐bowel cancer. Dis Colon Rectum 1983; 26(1):6–11.

    CAS  PubMed  Google Scholar 

  129. Young‐Fadok TM, Wolff BG, Nivatvongs S, Metzger PP, Ilstrup DM. Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial. Dis Colon Rectum 1998;41(3):277–283; discussion 283–285.

    PubMed  Google Scholar 

  130. Burt CA. Carcinoma of the ovaries secondary to cancer of the colon and rectum. Dis Colon Rectum 1960;3:352–357.

    CAS  PubMed  Google Scholar 

  131. Stearns MW Jr, Deddish MR. Five‐year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum 1959;2(2):169–172.

    PubMed  Google Scholar 

  132. Graffner HO, Alm PO, Oscarson JE. Prophylactic oophorectomy in colorectal carcinoma. Am J Surg 1983;146(2): 233–235.

    CAS  PubMed  Google Scholar 

  133. Koves I, Vamosi‐Nagy I, Besznyak I. Ovarian metastases of colorectal tumours. Eur J Surg Oncol 1993;19(6):633–635.

    CAS  PubMed  Google Scholar 

  134. Harcourt KF, Dennis DL. Laparotomy for “ovarian tumors” in unsuspected carcinoma of the colon. Cancer 1968;21(6): 1244–1246.

    CAS  PubMed  Google Scholar 

  135. Lindner V, Gasser B, Debbiche A, Tomb L, Vetter JM, Walter P. [Ovarian metastasis of colorectal adenocarcinomas. A clinico‐pathological study of 41 cases.] Ann Pathol 1999;19(6): 492–498.

    CAS  PubMed  Google Scholar 

  136. Rayson D, Bouttell E, Whiston F, Stitt L. Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma. J Surg Oncol 2000;75(3):186–192.

    CAS  PubMed  Google Scholar 

  137. Abu‐Rustum N, Barakat RR, Curtin JP. Ovarian and uterine disease in women with colorectal cancer. Obstet Gynecol 1997;89(1):85–87.

    PubMed  Google Scholar 

  138. Loy TS, Calaluce RD, Keeney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996;9(11):1040–1044.

    CAS  PubMed  Google Scholar 

  139. De Costanzo DC, Elias JM, Chumas JC. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen. Int J Gynecol Pathol 1997;16(3):245–249.

    CAS  Google Scholar 

  140. Wauters CC, Smedts F, Gerrits LG, Bosman FT, Ramaekers FC. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995;26(8):852–855.

    CAS  PubMed  Google Scholar 

  141. Dionigi A, Facco C, Tibiletti MG, Bernasconi B, Riva C, Capella C. Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis. Am J Clin Pathol 2000;114(1):111–122.

    CAS  PubMed  Google Scholar 

  142. Blamey SL, McDermott FT, Pihl E, Hughes ES. Resected ovarian recurrence from colorectal adenocarcinoma: a study of 13 cases. Dis Colon Rectum 1981;24(4):272–275.

    CAS  PubMed  Google Scholar 

  143. Herrera‐Ornelas L, Mittelman A. Results of synchronous surgical removal of primary colorectal adenocarcinoma and ovarian metastases. Oncology 1984;41(2):96–100.

    PubMed  Google Scholar 

  144. Huang PP, Weber TK, Mendoza C, Rodriguez‐Bigas MA, Petrelli NJ. Long‐term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol 1998;5(8): 695–698.

    CAS  PubMed  Google Scholar 

  145. Wright JD, Powell MA, MutchDG, et al. Synchronous ovarian metastases at the time of laparotomy for colon cancer. Gynecol Oncol 2004;92(3):851–855.

    PubMed  Google Scholar 

  146. Miller BE, Pittman B, Wan JY, Fleming M. Colon cancer with metastasis to the ovary at time of initial diagnosis. Gynecol Oncol 1997;66(3):368–371.

    CAS  PubMed  Google Scholar 

  147. Mac Keigan JM, Ferguson JA. Prophylactic oophorectomy and colorectal cancer in premenopausal patients. Dis Colon Rectum 1979;22(6):401–405.

    CAS  Google Scholar 

  148. Ballantyne GH, Reigel MM, Wolff BG, Ilstrup DM. Oophorectomy and colon cancer. Impact on survival. Ann Surg 1985;202(2):209–214.

    CAS  PubMed  Google Scholar 

  149. Sielezneff I, Salle E, Antoine K, Thirion X, Brunet C, Sastre B. Simultaneous bilateral oophorectomy does not improve prognosis of postmenopausal women undergoing colorectal resection for cancer. Dis Colon Rectum 1997;40(11):1299–1302.

    CAS  PubMed  Google Scholar 

  150. Kontoravdis A, Kalogirou D, Antoniou G, Kontoravdis N, Karakitsos P, Zourlas PA. Prophylactic oophorectomy in ovarian cancer prevention. Int J Gynaecol Obstet 1996;54(3): 257–262.

    CAS  PubMed  Google Scholar 

  151. Sightler SE, Boike GM, Estape RE, Averette HE. Ovarian cancer in women with prior hysterectomy: a 14‐year experience at the University of Miami. Obstet Gynecol 1991;78(4):681–684.

    CAS  PubMed  Google Scholar 

  152. Rozario D, Brown I, Fung MF, Temple L. Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cance? Am J Surg 1997;173(6):495–498.

    CAS  PubMed  Google Scholar 

  153. Barringer PL, Dockerty MB, Waugh JM, Bargen JA. Carcinoma of the large intestine: a new approach to the study of venous spread. Surg Gynecol Obstet 1954;98(1):62–72.

    CAS  PubMed  Google Scholar 

  154. Besbeas S, Stearns MW Jr. Osseous metastases from carcinomas of the colon and rectum. Dis Colon Rectum 1978;21(4): 266–268.

    CAS  PubMed  Google Scholar 

  155. Buckley N, Peebles Brown DA. Metastatic tumors in the hand from adenocarcinoma of the colon. Dis Colon Rectum 1987;30(2):141–143.

    CAS  PubMed  Google Scholar 

  156. Cascino TL, Leavengood JM, Kemeny N, Posner JB. Brain metastases from colon cancer. J Neurooncol 1983;1(3):203–209.

    CAS  PubMed  Google Scholar 

  157. Rovirosa A, Bodi R, Vicente P, Alastuey I, Giralt J, Salvador L. [Cerebral metastases in adenocarcinoma of the colon.] Rev Esp Enferm Dig 1991;79(4):281–283.

    CAS  PubMed  Google Scholar 

  158. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid‐tumor patients: natural history and results of treatment. Cancer 1981;48(2):384–394.

    CAS  PubMed  Google Scholar 

  159. Wronski M, Arbit E. Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 1999;85(8):1677–1685.

    CAS  PubMed  Google Scholar 

  160. Ko FC, Liu JM, Chen WS, Chiang JK, Lin TC, Lin JK. Risk and patterns of brain metastases in colorectal cancer: 27‐year experience. Dis Colon Rectum 1999;42(11):1467–1471.

    CAS  PubMed  Google Scholar 

  161. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987;107(4):459–465.

    CAS  PubMed  Google Scholar 

  162. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5‐fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206(6):685–693.

    CAS  PubMed  Google Scholar 

  163. Hohn DC, Stagg RJ, FriedmanMA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7(11):1646–1654.

    CAS  PubMed  Google Scholar 

  164. Wagman LD, Kemeny MM, LeongL, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990;8(11):1885–1893.

    CAS  PubMed  Google Scholar 

  165. Martin JK Jr, O'Connell MJ, WieandHS, et al. Intra‐arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990;125(8):1022–1027.

    PubMed  Google Scholar 

  166. Rougier P, Laplanche A, HuguierM, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long‐term results of a prospective randomized trial. J Clin Oncol 1992;10(7):1112–1118.

    CAS  PubMed  Google Scholar 

  167. Allen‐Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic‐artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344(8932):1255–1260.

    PubMed  Google Scholar 

  168. Kemeny NND, HollisDR, et al. Hepatic arterial infusion (HAI) versus systemic therapy for hepatic metastases from colorectal cancer: a CALGB randomized trial of efficacy, quality of life (QOL), cost effectiveness, and molecular markers. Proc Am Soc Clin Oncol 2003;22(abstr 1010):252.

    Google Scholar 

  169. Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 2003;8(6): 553–566.

    PubMed  Google Scholar 

  170. Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;119(6):647–651.

    CAS  PubMed  Google Scholar 

  171. Hughes KS, Simon R, SonghorabodiS, et al. Resection of the liver for colorectal carcinoma metastases: a multi‐institutional study of patterns of recurrence. Surgery 1986;100(2):278–284.

    CAS  PubMed  Google Scholar 

  172. Gayowski TJ, Iwatsuki S, MadariagaJR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994;116(4): 703–710; discussion 710–711.

    CAS  PubMed  Google Scholar 

  173. Scheele J, Stang R, Altendorf‐Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19(1):59–71.

    CAS  PubMed  Google Scholar 

  174. Fong Y, Blumgart LH, Cohen A, Fortner J, Brennan MF. Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 1994;220(5):657–662.

    CAS  PubMed  Google Scholar 

  175. Jenkins LT, Millikan KW, Bines SD, Staren ED, Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg 1997;63(7):605–610.

    CAS  PubMed  Google Scholar 

  176. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997;84(8):1136–1140.

    CAS  PubMed  Google Scholar 

  177. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132(5):505–510; discussion 511.

    CAS  PubMed  Google Scholar 

  178. Minagawa M, Makuuchi M, TorzilliG, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long‐term results. Ann Surg 2000;231(4):487–499.

    CAS  PubMed  Google Scholar 

  179. Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001;88(7):980–985.

    CAS  PubMed  Google Scholar 

  180. Choti MA, Sitzmann JV, TiburiMF, et al. Trends in long‐term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235(6):759–766.

    PubMed  Google Scholar 

  181. Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long‐term survival following liver resection for colorectal metastases. Br J Surg 2003;90(9):1131–1136.

    CAS  PubMed  Google Scholar 

  182. Mori M, Tomoda H, IshidaT, et al. Surgical resection of pulmonary metastases from colorectal adenocarcinoma. Special reference to repeated pulmonary resections. Arch Surg 1991;126(10):1297–1301; discussion 1302.

    CAS  PubMed  Google Scholar 

  183. McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ. Lung resection for colorectal metastases. 10‐year results. Arch Surg 1992;127(12):1403–1406.

    CAS  PubMed  Google Scholar 

  184. Yano T, Hara N, Ichinose Y, Yokoyama H, Miura T, Ohta M. Results of pulmonary resection of metastatic colorectal cancer and its application. J Thorac Cardiovasc Surg 1993;106(5): 875–879.

    CAS  PubMed  Google Scholar 

  185. Saclarides TJ, Krueger BL, Szeluga DJ, Warren WH, Faber LP, Economou SG. Thoracotomy for colon and rectal cancer metastases. Dis Colon Rectum 1993;36(5):425–429.

    CAS  PubMed  Google Scholar 

  186. van Halteren HK, van Geel AN, Hart AA, Zoetmulder FA. Pulmonary resection for metastases of colorectal origin. Chest 1995;107(6):1526–1531.

    CAS  PubMed  Google Scholar 

  187. Shirouzu K, Isomoto H, Hayashi A, Nagamatsu Y, Kakegawa T. Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma. Cancer 1995;76(3): 393–398.

    CAS  PubMed  Google Scholar 

  188. Girard P, Ducreux M, BaldeyrouP, et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol 1996;14(7):2047–2053.

    CAS  PubMed  Google Scholar 

  189. Okumura S, Kondo H, TsuboiM, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996;112(4):867–874.

    CAS  PubMed  Google Scholar 

  190. Zanella A, Marchet A, Mainente P, Nitti D, Lise M. Resection of pulmonary metastases from colorectal carcinoma. Eur J Surg Oncol 1997;23(5):424–427.

    CAS  PubMed  Google Scholar 

  191. Zink S, Kayser G, Gabius HJ, Kayser K. Survival, disease‐free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra‐pulmonary metastases. Eur J Cardiothorac Surg 2001;19(6):908–913.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Michael D'Angelica
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kamran Idrees
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philip B. Paty
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leslie H. Blumgart
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Professor of Surgery, Mayo Clinic College of Medicine, Chairman, Division of Colon and Rectal Surgery, Mayo Clinic Foundation, Rochester, MN, USA

    Bruce G. Wolff MD, FASCRS (Senior Editors) (Senior Editors)

  2. Professor of Surgery, Chief, Section of Colorectal Surgery, Washington University School of Medicine, St. Louis, MO, USA

    James W. Fleshman MD, FASCRS (Senior Editors) (Senior Editors)

  3. Chairman, Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA, USA

    David E. Beck MD, FASCRS (Senior Editors) (Senior Editors)

  4. Professor of Surgery, Mayo Clinic College of Medicine, Consultant, Colon and Rectal Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA

    John H. Pemberton MD, FASCRS (Senior Editors) (Senior Editors)

  5. Chief of Staff, Cleveland Clinic Florida, Weston, FL, USA

    Steven D. Wexner MD, FASCRS (Senior Editors) (Senior Editors)

  6. Victor W. Fazio Chair of Colorectal Surgery, Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA

    James M. Church BSc, MBChB, MMed Sci, FASCRS (Associate Editors) (Associate Editors)

  7. Professor of Surgery, Chief, Section of Colon and Rectal Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA

    Julio Garcia-Aguilar MD, PhD, FASCRS (Associate Editors) (Associate Editors)

  8. Department of Colon and Rectal Surgery, Lahey Clinic, Burlington, MA, USA

    Patricia L. Roberts MD, FASCRS (Associate Editors) (Associate Editors)

  9. Professor of Surgery, Head, Section of Colon and Rectal Surgery, Rush University Medical Center, Chicago, IL, USA

    Theodore J. Saclarides MD, FASCRS (Associate Editors) (Associate Editors)

  10. Division of Colon and Rectal Surgery, Department of Surgery, University of California, Irvine Medical Center, Orange, CA, USA

    Michael J. Stamos MD, FASCRS (Associate Editors) (Associate Editors)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this entry

Cite this entry

D'Angelica, M., Idrees, K., Paty, P.B., Blumgart, L.H. (2007). Colorectal Cancer: Metastatic (Palliation). In: Wolff, B.G., et al. The ASCRS Textbook of Colon and Rectal Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-36374-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-36374-5_34

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-24846-2

  • Online ISBN: 978-0-387-36374-5

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation